Drug Shortage Report for TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR
| Report ID | 161940 |
| Drug Identification Number | 02393549 |
| Brand name | TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR |
| Common or Proper name | EFAVIR/EMTRICIT/TENOF 600/200/300MG |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE EFAVIRENZ |
| Strength(s) | 300MG 200MG 600MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | J05AR |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-06-03 |
| Estimated end date | 2023-02-10 |
| Actual end date | 2023-02-10 |
| Shortage status | Resolved |
| Updated date | 2023-02-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v24 | 2023-02-11 | English | Compare |
| v23 | 2023-02-09 | French | Compare |
| v22 | 2023-02-09 | English | Compare |
| v21 | 2023-02-02 | French | Compare |
| v20 | 2023-02-02 | English | Compare |
| v19 | 2023-01-19 | French | Compare |
| v18 | 2023-01-19 | English | Compare |
| v17 | 2022-12-01 | French | Compare |
| v16 | 2022-12-01 | English | Compare |
| v15 | 2022-11-14 | French | Compare |
| v14 | 2022-11-14 | English | Compare |
| v13 | 2022-10-17 | French | Compare |
| v12 | 2022-10-17 | English | Compare |
| v11 | 2022-09-22 | French | Compare |
| v10 | 2022-09-22 | English | Compare |
| v9 | 2022-08-18 | French | Compare |
| v8 | 2022-08-18 | English | Compare |
| v7 | 2022-06-30 | French | Compare |
| v6 | 2022-06-30 | English | Compare |
| v5 | 2022-06-16 | French | Compare |